<p>Performance of previously published biomarker candidates associated with survival in non-small-cell lung cancer.</p
It is now widely established that management of lung cancer is much more complex and cannot be cente...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improvements in p...
Performance status (PS) is a commonly used factor in determining the appropriateness for chemotherap...
BackgroundPerformance status (PS) is an important factor in determining survival outcome in non-smal...
Journal Article; Research Support, Non-U.S. Gov't;Novel biomarkers are required to improve prognosti...
<p>Univariate analysis of factors associated with survival of patients with advanced non-small cell ...
Introduction Performance status (PS) is the only known clinical predictor of outcome in patients wit...
<p>Comparison of prognostic performance of noninvasive liver reserve markers.</p
Aim: Improve the prognostic prediction of clinical variables for non-small cell lung cancer (NSCLC),...
status on the choice of treatment for patients with non-small cell lung cancer; results of a populat...
Purpose/Objectives: To examine how routine laboratory biomarkers and clinical parameters available w...
It is now widely established that management of lung cancer is much more complex and cannot be cente...
Performance comparison of AutoEdge-CCP and other methods in novel drug associated cancers prediction...
PURPOSE: Currently, prediction of survival for non-small-cell lung cancer patients treated with (che...
It is now widely established that management of lung cancer is much more complex and cannot be cente...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improvements in p...
Performance status (PS) is a commonly used factor in determining the appropriateness for chemotherap...
BackgroundPerformance status (PS) is an important factor in determining survival outcome in non-smal...
Journal Article; Research Support, Non-U.S. Gov't;Novel biomarkers are required to improve prognosti...
<p>Univariate analysis of factors associated with survival of patients with advanced non-small cell ...
Introduction Performance status (PS) is the only known clinical predictor of outcome in patients wit...
<p>Comparison of prognostic performance of noninvasive liver reserve markers.</p
Aim: Improve the prognostic prediction of clinical variables for non-small cell lung cancer (NSCLC),...
status on the choice of treatment for patients with non-small cell lung cancer; results of a populat...
Purpose/Objectives: To examine how routine laboratory biomarkers and clinical parameters available w...
It is now widely established that management of lung cancer is much more complex and cannot be cente...
Performance comparison of AutoEdge-CCP and other methods in novel drug associated cancers prediction...
PURPOSE: Currently, prediction of survival for non-small-cell lung cancer patients treated with (che...
It is now widely established that management of lung cancer is much more complex and cannot be cente...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improvements in p...
DOI
Add to ORKG